{ 'indexed': {'date-parts': [[2023, 4, 19]], 'date-time': '2023-04-19T08:19:23Z', 'timestamp': 1681892363197},
'reference-count': 0,
'publisher': 'ST Bio-life',
'issue': '1',
'license': [ { 'start': { 'date-parts': [[2021, 1, 1]],
'date-time': '2021-01-01T00:00:00Z',
'timestamp': 1609459200000},
'content-version': 'unspecified',
'delay-in-days': 0,
'URL': 'http://creativecommons.org/licenses/by/4.0'}],
'content-domain': {'domain': [], 'crossmark-restriction': False},
'abstract': '<jats:p>The association of sleep disruption with a higher vulnerability to
\n'
'COVID-19 infection is a subject of major clinical importance. In patients with
\n'
'pneumonia associated with COVID-19 admitted to non-intensive care unit (NICU) several
\n'
'factors, like the disrupting influence of respiratory distress, medication, greater
\n'
'stress due to social isolation, and lack of appropriate exposure to environmental
\n'
'light can be instrumental to disrupt sleep/wake cycle. The
\n'
'therapeutic potential of melatonin to counteract the consequences of COVID-19
\n'
'infection has been advocated. Because of its wide-ranging effects as an
\n'
'antioxidant, anti-inflammatory, and immunomodulatory compound, melatonin could
\n'
'be unique in impairing the consequences of SARS-CoV-2 infection. Melatonin is
\n'
'also an effective chronobiotic agent to reverse the circadian disruption of social
\n'
'isolation and to control delirium in severely affected patients. Properly
\n'
'administered, melatonin may restore the optimal circadian pattern of the
\n'
'sleep-wake cycle and improve clinical condition in pneumonia associated with COVID-19
\n'
'patients. The present review article discusses the importance of maintaining
\n'
'normal sleep and circadian rhythmicity in NICU patients and provides
\n'
'preliminary data suggesting the efficacy of melatonin (9 mg/day) to reduce
\n'
'length of stay of pneumonia patients associated with COVID-19 in NICU. </jats:p>',
'DOI': '10.32794/mr11250089',
'type': 'journal-article',
'created': {'date-parts': [[2021, 1, 4]], 'date-time': '2021-01-04T02:01:11Z', 'timestamp': 1609725671000},
'page': '173-188',
'source': 'Crossref',
'is-referenced-by-count': 5,
'title': 'Efficacy of melatonin in non-intensive care unit patients with COVID-19 pneumonia and sleep '
'dysregulation',
'prefix': '10.32794',
'volume': '4',
'author': [ {'given': 'Luis I.', 'family': 'Brusco', 'sequence': 'first', 'affiliation': []},
{'given': 'Pablo', 'family': 'Cruz', 'sequence': 'first', 'affiliation': []},
{'given': 'Alicia V', 'family': 'Cangas', 'sequence': 'first', 'affiliation': []},
{'given': 'Carmen González', 'family': 'Rojas', 'sequence': 'first', 'affiliation': []},
{'given': 'Daniel E', 'family': 'Vigo', 'sequence': 'first', 'affiliation': []},
{'given': 'Daniel Pedro', 'family': 'Cardinali', 'sequence': 'first', 'affiliation': []}],
'member': '18079',
'published-online': {'date-parts': [[2021, 1, 1]]},
'container-title': 'Melatonin Research',
'original-title': [],
'deposited': { 'date-parts': [[2021, 1, 4]],
'date-time': '2021-01-04T02:01:34Z',
'timestamp': 1609725694000},
'score': 1,
'resource': {'primary': {'URL': 'https://www.melatonin-research.net/index.php/MR/article/view/125'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2021, 1, 1]]},
'references-count': 0,
'journal-issue': {'issue': '1', 'published-online': {'date-parts': [[2021, 1, 3]]}},
'URL': 'http://dx.doi.org/10.32794/mr11250089',
'relation': {},
'ISSN': ['2641-0281'],
'subject': [],
'container-title-short': 'Melatonin Res.',
'published': {'date-parts': [[2021, 1, 1]]}}
Late treatment is less effective
Please send us corrections, updates, or comments.
c19early involves the extraction of 100,000+ datapoints from
thousands of papers. Community updates
help ensure high accuracy.
Treatments and other interventions are complementary.
All practical, effective, and safe
means should be used based on risk/benefit analysis.
No treatment or intervention is 100% available and effective for all current
and future variants.
We do not provide medical advice. Before taking any medication,
consult a qualified physician who can provide personalized advice and details
of risks and benefits based on your medical history and situation. FLCCC and WCH
provide treatment protocols.